United Therapeutics (UTHR) Liabilities and Shareholders Equity (2009 - 2026)
United Therapeutics (UTHR) reported Liabilities and Shareholders Equity of $7.22 billion for Q2 2026, down 8.7% from $7.91 billion a year earlier but up 7.5% from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, United Therapeutics posted Liabilities and Shareholders Equity of $7.88 billion, up 7.0% from FY2024.
- Liabilities and Shareholders Equity has increased for 11 consecutive years, with a five-year compound annual growth rate of 11.3% (FY2020 to FY2025).
- By year, Liabilities and Shareholders Equity came in at $7.36 billion in FY2024 (+2.7%), $7.17 billion in FY2023 (+18.6%), $6.04 billion in FY2022 (+16.9%) and $5.17 billion in FY2021 (+12.0%).
- Five-year quarterly Liabilities and Shareholders Equity spans a low of $5.05 billion in Q3 2021 and a high of $7.91 billion in Q2 2025.
- Year over year, Liabilities and Shareholders Equity gained in six of the last eight quarters, with growth averaging 3.7%.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was Q3 2023 (growth of 21.5%); the low point was Q1 2026 (a decline of 13.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $6.71 billion (Q1 2026), $7.88 billion (Q4 2025) and $7.35 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | United Therapeutics | 23.13 Bn | 12.62 Bn | 683.80 Mn | 7.22 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.22 Bn |
| Mar 31, 2026 | 6.71 Bn |
| Dec 31, 2025 | 7.88 Bn |
| Sep 30, 2025 | 7.35 Bn |
| Jun 30, 2025 | 7.91 Bn |
| Mar 31, 2025 | 7.74 Bn |
| Dec 31, 2024 | 7.36 Bn |
| Sep 30, 2024 | 7.12 Bn |
| Jun 30, 2024 | 6.72 Bn |
| Mar 31, 2024 | 6.50 Bn |
| Dec 31, 2023 | 7.17 Bn |
| Sep 30, 2023 | 7.02 Bn |
| Jun 30, 2023 | 6.68 Bn |
| Mar 31, 2023 | 6.35 Bn |
| Dec 31, 2022 | 6.04 Bn |
| Sep 30, 2022 | 5.78 Bn |
| Jun 30, 2022 | 5.54 Bn |
| Mar 31, 2022 | 5.36 Bn |
| Dec 31, 2021 | 5.17 Bn |
| Sep 30, 2021 | 5.05 Bn |
API Access
United Therapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();